Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer with PSA Screening By Ogkologos - November 4, 2025 374 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ERSPC study Source RELATED ARTICLESMORE FROM AUTHOR Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma ESMO Welcomes the European Parliament’s (EP) Call for a Sustainable Cancer Workforce to Deliver Quality Care for Patients with Cancer ESMO Welcomes the Inclusion of Tobacco Provisions in European Parliament’s Report on Cardiovascular Diseases and Calls for Additional Measures to Prevent Cancer MOST POPULAR UK health inequalities: 20,000 more cancer cases a year in the... September 29, 2020 EMA Recommends Extension of Indications for Atezolizumab September 28, 2020 Should CAR T Cells Be Used Earlier in People with Non-Hodgkin... January 13, 2022 Manageable Safety and Promising Activity of Neoadjuvant Pembrolizumab plus Vibostolimab, Pembrolizumab... January 21, 2025 Load more HOT NEWS Radiotherapy Can Be Safely Omitted in Older Women with Low-Risk, HR-positive... Jimmy Carter Signed This Treaty Demanding An End To Violence Against... Stressed out – the cancer cells that survive chemotherapy, but at... Vaping Pods Produce High Nicotine Levels in Young Users
